Medium- and long-term recurrence after radioiodine therapy for differentiated thyroid carcinoma with recombinant human thyrotropin: a meta-analysis

IntroductionRadioactive iodine (RAI) is commonly used in the management of differentiated thyroid cancers (DTCs). However, the long-term efficacy and the risk of tumor recurrence associated with it remain unclear. In particular, the comparison between recombinant human thyrotropin (rhTSH) and thyroi...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Qixian Yao, Lili Song, Jun Xu, Zhongliang Wu
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2024-12-01
Serija:	Frontiers in Endocrinology
Teme:	recombinant human thyroid stimulating hormone differentiated thyroid carcinoma long-term recurrence thyroid hormone withdrawal radioactive iodine
Online dostop:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1474121/full
Oznake:	Označite Brez oznak, prvi označite!